Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma.
J Hematol Oncol. 2021 Oct 29;14(1):176. doi: 10.1186/s13045-021-01191-2.
J Hematol Oncol. 2021.
PMID: 34715891
Free PMC article.
Review.